NVACF:OTC-Nova Cannabis Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 1.264

Change

0.00 (0.00)%

Market Cap

USD 0.08B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Nova Cannabis Inc. operates retail cannabis stores with a focus on the recreational-use cannabis market in Canada. The company is headquartered in Edmonton, Canada. Nova Cannabis Inc. operates as a subsidiary of SNDL Inc.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 12.16B
JDHIF JD Health International Inc

N/A

USD 9.97B
ALBHF Alibaba Health Information Tec..

N/A

USD 8.27B
RADLY Raia Drogasil SA ADR

-0.29 (-5.87%)

USD 7.74B
CLCGY Clicks Group Ltd

+0.63 (+1.50%)

USD 5.11B
SHPPF Shop Apotheke Europe N.V

N/A

USD 3.23B
SAEYY Shop Apotheke Europe N.V

N/A

USD 3.16B
NOTR Nowtransit Inc

N/A

USD 0.55B
ZRSEF Zur Rose Group AG

-3.47 (-8.17%)

USD 0.54B
PNPL Pineapple Express

N/A

USD 0.01B

ETFs Containing NVACF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 93.18% 76% C+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 93.18% 76% C+ 84% B
Trailing 12 Months  
Capital Gain 122.14% 82% B 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 122.14% 82% B 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.43% 48% F 51% F
Dividend Return 8.43% 48% F 47% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 80.77% 60% D- 39% F
Risk Adjusted Return 10.43% 44% F 43% F
Market Capitalization 0.08B 57% F 56% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.